Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silke Raffegerst

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Bioinformatics (Oxford, England)|February 4, 2015
Expitope: a web server for epitope expressionKerstin Haase, Silke Raffegerst, Dolores J Schendel, et al.
Bioinformatics (Oxford, England)|September 11, 2016
Assessment of cancer and virus antigens for cross-reactivity in human tissuesVictor Jaravine, Silke Raffegerst, Dolores J Schendel, et al.
BMC Cancer|December 29, 2017
Expitope 2.0: a tool to assess immunotherapeutic antigens for their potential cross-reactivity against naturally expressed proteins in human tissuesVictor Jaravine, Anja Mösch, Silke Raffegerst, et al.
Frontiers in Genetics|December 5, 2019
Machine Learning for Cancer Immunotherapies Based on Epitope Recognition by T Cell ReceptorsAnja Mösch, Silke Raffegerst, Manon Weis, et al.
Journal of Innate Immunity|December 24, 2010
The CD6 scavenger receptor is differentially expressed on a CD56 natural killer cell subpopulation and contributes to natural killer-derived cytokine and chemokine secretionMonika Braun, Bernadette Müller, Dominik ter Meer, et al.
Cancer Cell|December 15, 2012
Pharmacologic inhibition of MALT1 protease by phenothiazines as a therapeutic approach for the treatment of aggressive ABC-DLBCLDaniel Nagel, Stefani Spranger, Michelle Vincendeau, et al.
Cancers|September 27, 2025
First-in-Human Study of MDG1011, a TCR-T Therapy Directed Against HLA-A*02:01-Restricted PRAME Antigen for High-Risk Myeloid and Lymphoid NeoplasmsSimone Thomas, Martin Wermke, Vladan Vučinić, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Bioinformatics (Oxford, England)|February 4, 2015
Expitope: a web server for epitope expressionKerstin Haase, Silke Raffegerst, Dolores J Schendel, et al.
Bioinformatics (Oxford, England)|September 11, 2016
Assessment of cancer and virus antigens for cross-reactivity in human tissuesVictor Jaravine, Silke Raffegerst, Dolores J Schendel, et al.
BMC Cancer|December 29, 2017
Expitope 2.0: a tool to assess immunotherapeutic antigens for their potential cross-reactivity against naturally expressed proteins in human tissuesVictor Jaravine, Anja Mösch, Silke Raffegerst, et al.
Frontiers in Genetics|December 5, 2019
Machine Learning for Cancer Immunotherapies Based on Epitope Recognition by T Cell ReceptorsAnja Mösch, Silke Raffegerst, Manon Weis, et al.
Journal of Innate Immunity|December 24, 2010
The CD6 scavenger receptor is differentially expressed on a CD56 natural killer cell subpopulation and contributes to natural killer-derived cytokine and chemokine secretionMonika Braun, Bernadette Müller, Dominik ter Meer, et al.
Cancer Cell|December 15, 2012
Pharmacologic inhibition of MALT1 protease by phenothiazines as a therapeutic approach for the treatment of aggressive ABC-DLBCLDaniel Nagel, Stefani Spranger, Michelle Vincendeau, et al.
Cancers|September 27, 2025
First-in-Human Study of MDG1011, a TCR-T Therapy Directed Against HLA-A*02:01-Restricted PRAME Antigen for High-Risk Myeloid and Lymphoid NeoplasmsSimone Thomas, Martin Wermke, Vladan Vučinić, et al.
Pageof 1